ProKidney Corp. • PROK

Capital at risk.

About ProKidney Corp.
Ticker
info
PROK
Trading on
info
NASDAQ
ISIN
info
KYG7S53R1049
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Bruce Culleton M.D.
Headquarters
info
2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103
Employees
info
204
Website
info
https://prokidney.com
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Metrics
BasicAdvanced
Market cap
info
$1.81B
P/E ratio
info
-
EPS
info
-$0.59
Dividend Yield
info
0.00%
Beta
info
1.46
Forward P/E ratio
info
0
EBIDTA
info
$-174M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.81B
Average daily volume
info
0.9M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
5,921
Price to book
info
97.15
Earnings
EPS
info
-$0.59
EPS estimate (current quarter)
info
-$0.15
EPS estimate (next quarter)
info
-$0.16
EBITDA
info
$-174M
Revenues (TTM)
info
$0.3M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.46
52-week High
info
$2.59
52-week Low
info
$0.46
50-day moving average
info
$0.80
200-day moving average
info
$1.43
Short ratio
info
26.84
Short %
info
18.18%
Management effectiveness
ROE (TTM)
info
-45.28%
ROA (TTM)
info
-28.29%
Profit margin
info
0.00%
Gross profit margin
info
$0.3M
Operating margin
info
-17,994.78%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
130M
Float
info
78.2M
Insiders %
info
30.05%
Institutions %
info
41.88%
Analyst Insights & forecasts
info

58% Buy

42% Hold

0% Sell

Based on information from 7 analysts.

Average price target

info
$4.40
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.16
-$0.17
5.88%
Q2 • 24Beat
-$0.14
-$0.15
5.40%
Q3 • 24Beat
-$0.17
-$0.15
-14.86%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0.1M
$-21.3M
-27,997.37%
Q4 • 24
$0.2M
$-16.7M
-7,275.65%
Q1 • 25
202.63%
-21.36%
-74.01%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$441M
$39.4M
8.94%
Q4 • 24
$406M
$36.1M
8.89%
Q1 • 25
-7.94%
-8.50%
-0.61%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-24.2M
$15.1M
$0.1M
$-49.7M
Q4 • 24
$-29.6M
$28.3M
$-0M
$-30.7M
Q1 • 25
22.43%
87.59%
-109.76%
-38.15%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a ProKidney Corp. share?
Collapse

ProKidney Corp. shares are currently traded for undefined per share.

How many shares does ProKidney Corp. have?
Collapse

ProKidney Corp. currently has 130M shares.

Does ProKidney Corp. pay dividends?
Collapse

No, ProKidney Corp. doesn't pay dividends.

What is ProKidney Corp. 52 week high?
Collapse

ProKidney Corp. 52 week high is $2.59.

What is ProKidney Corp. 52 week low?
Collapse

ProKidney Corp. 52 week low is $0.46.

What is the 200-day moving average of ProKidney Corp.?
Collapse

ProKidney Corp. 200-day moving average is $1.43.

Who is ProKidney Corp. CEO?
Collapse

The CEO of ProKidney Corp. is Dr. Bruce Culleton M.D..

How many employees ProKidney Corp. has?
Collapse

ProKidney Corp. has 204 employees.

What is the market cap of ProKidney Corp.?
Collapse

The market cap of ProKidney Corp. is $1.81B.

What is the P/E of ProKidney Corp.?
Collapse

The current P/E of ProKidney Corp. is null.

What is the EPS of ProKidney Corp.?
Collapse

The EPS of ProKidney Corp. is -$0.59.

What is the PEG Ratio of ProKidney Corp.?
Collapse

The PEG Ratio of ProKidney Corp. is null.

What do analysts say about ProKidney Corp.?
Collapse

According to the analysts ProKidney Corp. is considered a buy.